2-Jul-2026
No headlines found.
Privia Health Enters New Jersey
Globe Newswire (Wed, 27-May 9:00 AM ET)
Privia Health Reports First Quarter 2026 Financial Results
Globe Newswire (Thu, 7-May 6:00 AM ET)
Privia Health to Report First Quarter 2026 Results on Thursday, May 7
Globe Newswire (Wed, 8-Apr 9:00 AM ET)
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.
Privia Health Group trades on the NASDAQ stock market under the symbol PRVA.
As of July 2, 2026, PRVA stock price climbed to $27.36 with 832,422 million shares trading.
PRVA has a beta of 0.68, meaning it tends to be less sensitive to market movements. PRVA has a correlation of 0.07 to the broad based SPY ETF.
PRVA has a market cap of $3.45 billion. This is considered a Mid Cap stock.
Last quarter Privia Health Group reported $604 million in Revenue and $.19 earnings per share. This beat revenue expectation by $42 million and missed earnings estimates by -$.03.
In the last 3 years, PRVA traded as high as $28.23 and as low as $15.92.
The top ETF exchange traded funds that PRVA belongs to (by Net Assets): IJR, IWM, VTI, VB, VBK.
PRVA has underperformed the market in the last year with a return of +21.4%, while SPY returned +21.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in PRVA shares. However, PRVA has outperformed the market in the last 3 month and 2 week periods, returning +29.9% and +16.9%, while SPY returned +14.0% and +1.0%, respectively. This indicates PRVA has been having a stronger performance recently.
PRVA support price is $26.31 and resistance is $27.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRVA shares will trade within this expected range on the day.